How much funding has Oricell Therapeutics raised?

Oricell Therapeutics has raised $364.0M in total funding, most recently a Venture Round.

Who are Oricell Therapeutics's investors?

Oricell Therapeutics's investors include Qiming VP, Vivo Capital, Beijing Medical and Health Care Industry Investment Fund, Quan Capital.

When was Oricell Therapeutics founded?

Oricell Therapeutics was founded in 2019.

Where is Oricell Therapeutics headquartered?

Oricell Therapeutics is headquartered in Shanghai, China.

What industry is Oricell Therapeutics in?

Oricell Therapeutics operates in Oncology, Therapeutics, Biotech.

How many employees does Oricell Therapeutics have?

Oricell Therapeutics has 51-200 employees.

Oricell Therapeutics

原启生物 - 成为创新驱动的全球领先，肿瘤免疫治疗新药的创制者

Shanghai, China · Founded 2019 · $364.0M raised

Oncology

Therapeutics

Biotech

Headquarters: Shanghai
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: oricell.com
Total Funding: $364.0M
Last Round: $110.0M Venture RoundApr 2026
Rounds: 5

About

Oricell Therapeutics is a clinical-stage biopharmaceutical company committed to developing innovative and affordable immunotherapies for hematological malignancies and solid tumors. Its lead program, OriCAR-017, is a GPRC5D-targeting autologous CAR-T therapy for relapsed/refractory multiple myeloma with FDA and NMPA IND approvals. Oricell also advances Ori-C101, a GPC3-targeting CAR-T for hepatocellular carcinoma, leveraging its proprietary OriAb antibody library platform.

Summary

Oricell Therapeutics is an Oncology company based in Shanghai, China, founded in 2019. It has raised $364.0M in total across 5 rounds, most recently a $110.0M Venture Round round in Apr 2026. Investors include Qiming VP, Vivo Capital and Beijing Medical and Health Care Industry Investment Fund.